Giva has just raised a whopping ₹530 crore. The funding round was led by Creaegis, with support from existing investors like Premji Invest, Epiq Capital, and Edelweiss Discovery Fund. This fresh capital is set to supercharge Giva’s push into lab-grown diamond jewellery.
Started in 2019 by Ishendra Agarwal and Nikita Prasad, Giva began as a silver jewellery brand. It offered 925 sterling silver to fashion-forward Indian buyers. Since then, it’s expanded into gold and now, lab-grown diamonds—a smart move given the global shift in consumer choices.
Lab-grown diamonds are booming. They look like real diamonds, cost much less, and are more sustainable. For many young buyers, especially in India’s Tier 2 cities, they’re the obvious pick. Startups like Aukera Jewellery, True Diamonds, and Limelight Diamonds are all in the race, but Giva is playing to win.
With over 240 stores already, Giva now plans to open 145–150 more this year alone. The focus is on Tier 2 cities, where demand is rising fast. The brand also plans to boost its digital presence and upgrade its tech-backed supply chain.
Also Read Britannia Industries Shares Rise 2% Today, Backed by Strong EPS and Solid Margins
“We’re focused on giving modern Indian consumers a better fine jewellery experience,” said Giva founder Ishendra Agarwal. “This round helps us push harder toward market leadership.”
In a major internal update, the company also announced that its COO, Aditya Labroo, is now a co-founder. A sign that Giva values deep commitment and internal growth—rare, but refreshing.
According to Prakash Parthasarathy, Managing Partner at Creaegis, Giva has everything going for it: product innovation, a strong digital presence, and solid omni-channel capabilities. “We’ve backed many strong D2C brands before, and we believe Giva is next in line to lead,” he said.
Lab-grown diamonds are no longer a niche. They’re the future of fine jewellery. Giva’s bold move and big funding show it knows this—and it’s ready to lead the charge.
Also Read Arisinfra Solutions List at ₹205 on NSE, 8% Below IPO Price Despite 2.65x Subscription
